A Study to Evaluate the Safety, Tolerability of DN1508052-01 in Advanced Solid Tumors
Clinical trial NCT03934359 · COMPLETED
Trial details
- NCT number
- NCT03934359
- Sponsor
- Shanghai De Novo Pharmatech Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-18
- Primary completion
- 2022-08-30
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.